Cargando…
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
Rare diseases are a serious public health problem that presents unique challenges to many countries. There is no internationally accepted definition for rare diseases. Patients suffering from rare cancers often face challenges, including late or incorrect diagnoses, difficulties finding clinical exp...
Autores principales: | Shash, Emad, Negrouk, Anastassia, Marreaud, Sandrine, Golfinopoulos, Vassilis, Lacombe, Denis, Meunier, Francoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660157/ https://www.ncbi.nlm.nih.gov/pubmed/23717342 http://dx.doi.org/10.3332/ecancer.2013.321 |
Ejemplares similares
-
Precision Medicine: From “Omics” to Economics towards Data-Driven Healthcare - Time for European Transformation
por: Lacombe, Denis, et al.
Publicado: (2017) -
International Rare Cancers Initiative (IRCI)
por: Keat, Nicola, et al.
Publicado: (2013) -
Making Change Happen in Health
por: Horgan, Denis, et al.
Publicado: (2017) -
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN
por: Morfouace, Marie, et al.
Publicado: (2020) -
Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
por: Lalova, Teodora, et al.
Publicado: (2020)